Annual report pursuant to Section 13 and 15(d)

Common Stock Warrants (Tables)

v3.24.1.1.u2
Common Stock Warrants (Tables)
12 Months Ended
Dec. 31, 2023
Common Stock Warrants  
Schedule of Warrants to Purchase Common Stock Outstanding

The following is a summary of information about our warrants to purchase common stock outstanding at December 31, 2023.

 

    Shares Underlying  
Shares Underlying Warrants Outstanding   Warrants Exercisable  
          Weighted                    
    Shares     Average     Weighted     Shares     Weighted  
Range of   Underlying     Remaining     Average     Underlying     Average  
Exercise   Warrants     Contractual     Exercise     Warrants     Exercise  
Prices   Outstanding     Life     Price     Exercisable     Price  
                                         
$ 0.25-$0.50     14,011,650       1.91 years     $ 0.29       14,011,650     $ 0.29  
Schedule of Fair value Assumption of Warrants

The fair value of each warrant grant is estimated on the date of grant using the Black-Scholes option pricing model with the following weighted-average assumptions used for grants under the fixed option plan:

 

    December 31,     December 31,  
    2023     2022  
             
Average risk-free interest rates     3.60 %     3.79 %
Average expected life (in years)     5.00       5.00  
Volatility     151 %     157 %
Schedule of Warrants Activity

The following is a summary of activity of outstanding common stock warrants:

 

          Weighted  
          Average  
    Number     Exercise  
    of Shares     Prices  
Balance, December 31, 2021     11,011,650     $ 0.30  
Warrants granted     500,000       0.25  
Balance, December 31, 2022     11,511,650       0.29  
Warrants granted     2,500,000       0.25  
Balance, December 31, 2023     14,011,650     $ 0.29  
                 
Exercisable, December 31, 2023     14,011,650     $ 0.29